Feb 1, 2017 A phase 2 proof of concept study of MBX-8025 in patients with Primary Biliary Cholangitis (PBC) who are inadequate responders to ursodeoxycholic acid (UDCA)
Nov 11, 2016 Clinical Study Start-up Time Lines for Rare Orphan Diseases: Can We Do Better? The Example of Primary Biliary Cholangitis
Sep 1, 2016 A Pilot study of MBX-8025 in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)